| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |